Eline Berends

Eline Berends

Auto-generated profile, based on publicly available information

Eline Berends

Department of Internal Medicine, Maastricht University, Maastricht, The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2023 in Biomechanics and Modeling in Mechanobiology
Verified
Journal Article
Open access
PDF file
AGAlessandro Giudici
Alessandro Giudici
KLKoen W. F. van der Laan
Koen W. F. van der Laan
MBMyrthe M. van der Bruggen
Myrthe M. van der Bruggen
SPShaiv Parikh
Shaiv Parikh
EBEline Berends
Eline Berends
BSBart Spronck
Bart Spronck
Arteries exhibit fully nonlinear viscoelastic behaviours (i.e. both elastically and viscously nonlinear). While elastically nonlinear arterial models are well established, effective mathematical descriptions of nonlinear viscoelasticity are lacking. Quasi-linear viscoelasticity (QLV) offers a convenient way to mathematically describe viscoelasticity, but its viscous linearity assumption is unsuitable for whole-wall vascular applications. Conversely, application of fully nonlinear viscoelastic models, involving deformation-dependent viscous parameters, to experimental data is impractical and often reduces to identifying specific solutions for each tested loading condition. The present study aims to address this limitation: By applying QLV theory at the wall constituent rather than at the whole-wall level, the deformation-dependent relative contribution of the constituents allows to capture nonlinear viscoelasticity with a unique set of deformation-independent model parameters. Five murine common carotid arteries were subjected to a protocol of quasi-static and harmonic, pseudo-physiological biaxial loading conditions to characterise their viscoelastic behaviour. The arterial wall was modelled as a constrained mixture of an isotropic elastin matrix and four families of collagen fibres. Constituent-based QLV was implemented by assigning different relaxation functions to collagen- and elastin-borne parts of the wall stress. Nonlinearity in viscoelasticity was assessed via the pressure dependency of the dynamic-to-quasi-static stiffness ratio. The experimentally measured ratio increased with pressure, from 1.03 $$\pm$$ ± 0.03 (mean $$\pm$$ ± standard deviation) at 80–40 mmHg to 1.58 $$\pm$$ ± 0.22 at 160–120 mmHg. Constituent-based QLV captured well this trend by attributing the wall viscosity predominantly to collagen fibres, whose recruitment starts at physiological pressures. In conclusion, constituent-based QLV offers a practical and effective solution to model arterial viscoelasticity.

Verified
Journal Article
Open access
PDF file
IMIrina Milanova
Irina Milanova
NKNikita L. Korpel
Nikita L. Korpel
FCFelipe Correa-da-Silva
Felipe Correa-da-Silva
EBEline Berends
Eline Berends
SOSamar Osman
Samar Osman
CYChun-Xia Yi
Chun-Xia Yi
Obesity and type 2 diabetes mellitus (T2DM) are highly prevalent disorders, associated with insulin resistance and chronic inflammation. The brain is key for energy homeostasis and contains many insulin receptors. Microglia, the resident brain immune cells, are known to express insulin receptors (InsR) and to be activated by a hypercaloric environment. The aim of this study was to evaluate whether microglial insulin signaling is involved in the control of systemic energy homeostasis and whether this function is sex-dependent. We generated a microglia-specific knockout of the InsR gene in male and female mice and exposed them to control or obesogenic dietary conditions. Following 10 weeks of diet exposure, we evaluated insulin tolerance, energy metabolism, microglial morphology and phagocytic function, and neuronal populations. Lack of microglial InsR resulted in increased plasma insulin levels and insulin resistance in obese female mice. In the brain, loss of microglial InsR led to a decrease in microglial primary projections in both male and female mice, irrespective of the diet. In addition, in obese male mice lacking microglial InsR the number of proopiomelanocortin neurons was decreased, compared to control diet, while no differences were observed in female mice. Our results demonstrate a sex-dependent effect of microglial InsR-signaling in physiology and obesity, and stress the importance of a heterogeneous approach in the study of diseases such as obesity and T2DM.

24 September 2024 in The Journal of Physiology
Verified
Journal Article
Open access
EBEline Berends
Eline Berends
MPMargarita G. Pencheva
Margarita G. Pencheva
MWMarjo P. H. van de Waarenburg
Marjo P. H. van de Waarenburg
JSJean L. J. M. Scheijen
Jean L. J. M. Scheijen
DHDenise J. H. P. Hermes
Denise J. H. P. Hermes
CSCasper G. Schalkwijk
Casper G. Schalkwijk
Diabetes is associated with cognitive impairment, but the underlying mechanism remains unclear. Methylglyoxal (MGO), a precursor to advanced glycation endproducts (AGEs), is elevated in diabetes and linked to microvascular dysfunction. In this study, overexpression of the MGO‐detoxifying enzyme glyoxalase 1 (Glo1) was used in a mouse model of diabetes to explore whether MGO accumulation in diabetes causes cognitive impairment. Diabetes was induced with streptozotocin. Fasting blood glucose, cognitive function, cerebral blood flow, neurovascular coupling (NVC), Glo1 activity, MGO and AGEs were assessed. In diabetes, MGO‐derived hydroimidazolone‐1 increased in the cortex, and was decreased in Glo1‐overexpressing mice compared to controls. Visuospatial memory was decreased in diabetes, but not in Glo1/diabetes. NVC response time was slightly increased in diabetes, and normalised in the Glo1‐overexpressing group. No impact of diabetes or Glo1 overexpression on blood–brain barrier integrity or vascular density was observed. Diabetes induced a mild visuospatial memory impairment and slightly reduced NVC response speed and these effects were mitigated by Glo1. This study shows a link between MGO‐related AGE accumulation and cerebrovascular/cognitive functions in diabetes. Modulation of the MGO–Glo1 pathway may be a novel intervention strategy in patients with diabetes who have cerebrovascular complications. image Key points: Diabetes is associated with an increased risk of stroke, cognitive decline, depression and Alzheimer's disease, but the underlying mechanism remains unclear. Methylglyoxal (MGO), a highly reactive by‐product of glycolysis, plays an important role in the development of diabetes‐associated microvascular dysfunction in the periphery and is detoxified by the enzyme glyoxalase 1. Diabetes reduced visuospatial memory in mice and slowed the neurovascular coupling response speed, which was improved by overexpression of glyoxalase 1. MGO formation and MGO‐derived advanced glycation endproduct (AGE) accumulation in the brain of diabetic mice are associated with a slight reduction in neurovascular coupling and mild cognitive impairment. The endogenous formation of MGO, and the accumulation of MGO‐derived AGEs, might be a potential target in reducing the risk of vascular cognitive impairment in people with diabetes.

17 October 2024 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
EBEline Berends
Eline Berends
PVPhilippe Vangrieken
Philippe Vangrieken
NANaima Amiri
Naima Amiri
MWMarjo P. H. van de Waarenburg
Marjo P. H. van de Waarenburg
JSJean L. J. M. Scheijen
Jean L. J. M. Scheijen
Sébastien FoulquierSébastien Foulquier
Sébastien Foulquier
Diabetes and other age-related diseases are associated with an increased risk of cognitive impairment, but the underlying mechanisms remain poorly understood. Methylglyoxal (MGO), a by-product of glycolysis and a major precursor in the formation of advanced glycation end-products (AGEs), is increased in individuals with diabetes and other age-related diseases and is associated with microvascular dysfunction. We now investigated whether increased levels of circulating MGO can lead to cerebral microvascular dysfunction, blood–brain barrier (BBB) dysfunction, and cognitive impairment. Mice were supplemented or not with 50 mM MGO in drinking water for 13 weeks. Plasma and cortical MGO and MGO-derived AGEs were measured with UPLC-MS/MS. Peripheral and cerebral microvascular integrity and inflammation were investigated. Cerebral blood flow and neurovascular coupling were investigated with laser speckle contrast imaging, and cognitive tests were performed. We found a 2-fold increase in plasma MGO and an increase in MGO-derived AGEs in plasma and cortex. Increased plasma MGO did not lead to cerebral microvascular dysfunction, inflammation, or cognitive decline. This study shows that increased concentrations of plasma MGO are not associated with cerebral microvascular dysfunction and cognitive impairment in healthy mice. Future research should focus on the role of endogenously formed MGO in cognitive impairment.

1 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
EBEline Berends
Eline Berends
PVPhilippe Vangrieken
Philippe Vangrieken
NANaima Amiri
Naima Amiri
MWMarjo P.H. van de Waarenburg
Marjo P.H. van de Waarenburg
JSJean L.J.M. Scheijen
Jean L.J.M. Scheijen
Sébastien FoulquierSébastien Foulquier
Sébastien Foulquier
Diabetes and other age-related diseases are associated with an increased risk of cognitive impairment, but the underlying mechanisms remain poorly understood. Methylglyoxal (MGO), a by-product of glycolysis and a major precursor in the formation of advanced glycation end- products (AGEs), is increased in individuals with diabetes and other age-related diseases, and is associated with microvascular dysfunction. We now investigated whether increased levels of circulating MGO can lead to cerebral microvascular dysfunction, blood brain barrier (BBB) dysfunction, and cognitive impairment. Mice were supplemented or not with 50 mM MGO in drinking water for 13 weeks. Plasma and cortical MGO and MGO-derived AGEs were measured with UPLC-MS/MS. Peripheral and cerebral microvascular integrity and inflammation were investigated. Cerebral blood flow and neurovascular coupling were investigated with laser speckle contrast imaging, and cognitive tests were performed. We found a 2-fold increase in plasma MGO and an increase in MGO-derived AGEs in plasma and cortex. Increased plasma MGO did not lead to cerebral microvascular dysfunction, inflammation, nor cognitive decline. This study shows that increased concentrations of plasma MGO are not associated with cerebral microvascular dysfunction and cognitive impairment in healthy mice. Future research should focus on the role of endogenously formed MGO in cognitive impairment.

29 January 2026 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
EBEline Berends
Eline Berends
SESimone J.P.M. Eussen
Simone J.P.M. Eussen
WBWalter H. Backes
Walter H. Backes
PDPieter C. Dagnelie
Pieter C. Dagnelie
JJJacobus F.A. Jansen
Jacobus F.A. Jansen
CSCasper G. Schalkwijk
Casper G. Schalkwijk
Cerebral small vessel disease (CSVD) and dementia are increasingly prevalent in the aging population. Diabetes is a major risk factor for CSVD and cognitive impairment, but the underlying mechanisms remain unclear. Methylglyoxal (MGO), a glycolysis by-product and precursor of advanced glycation endproducts (AGEs), is elevated in diabetes and linked to microvascular complications. The aim of this study is to investigate the association between levels of MGO in plasma with MRI-derived markers of CSVD and cognitive impairment in a population-based setting. Cross-sectional data from The Maastricht Study, a population-based cohort with an oversampling of type 2 diabetes (age 59.7 ± 8.2 years, 49.9 % male, 26 % type 2 diabetes), were analysed. Plasma MGO concentrations were measured using UPLC-MS/MS after overnight fasting. Participants underwent MRI (n = 1789) and cognitive testing (n = 2515). CSVD markers included white matter hyperintensity volume, lacunar infarcts, and cerebral microbleeds. Logistic and linear regressions, adjusted for confounders, assessed the associations between plasma MGO levels, CSVD markers, and cognitive function. No linear associations were found in any of the outcomes. When dividing the population into tertiles (lowest, intermediate, highest) based on plasma MGO concentration, intermediate compared to lowest levels of plasma MGO were associated with increased odds of having a lacunar infarct (OR: 2.26, 95 %CI: 1.27; 4.01). This was not observed for highest plasma MGO (OR: 1.56, 95 %CI: 0.85; 2.86). Intermediate plasma MGO levels were associated with the presence of more lacunar infarcts. Further research is needed to determine whether MGO contributes to lacunar infarct formation in a causal manner.